Molecular mechanism of innate signalling in the immune and nervous system.
In plain English
AI plain-English summaryThe body’s frontline immune defences and the brain’s waste-cleaning cells share a common molecular switch—and this project will map exactly how that switch works in both settings. Toll-like receptors (TLRs) are proteins that normally detect invading microbes and trigger inflammation. But in the brain, the same receptors can become chronically activated in microglia, the resident immune cells, contributing to neuron death in Parkinson’s disease. The researcher will use structural biology to determine how TLRs assemble into signalling platforms, and how a protein called LRRK2—a known genetic risk factor for Parkinson’s—interacts with these receptors. They will also identify which cellular factors activate TLRs in the absence of infection, and which genes and proteins are switched on when microglia become toxic. This is fundamental science. It does not promise a new drug tomorrow. But understanding the molecular handshake between TLRs and LRRK2 could reveal specific points where the neurodegenerative cascade might be interrupted. Past work on innate immune signalling has already led to therapies for autoimmune diseases; a similar mechanistic grasp of TLR-driven neurotoxicity could open routes to slow or halt Parkinson’s progression.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Investigator Award in SciencePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know